Imported malaria: key messages in an era of elimination.


Journal

Clinical medicine (London, England)
ISSN: 1473-4893
Titre abrégé: Clin Med (Lond)
Pays: England
ID NLM: 101092853

Informations de publication

Date de publication:
03 2019
Historique:
entrez: 16 3 2019
pubmed: 16 3 2019
medline: 21 4 2020
Statut: ppublish

Résumé

Despite concerted efforts to eliminate malaria, it remains a major global cause of morbidity and mortality with over 200 million annual cases. Significant gains have been made, with the annual global malaria incidence and mortality halving over the past twenty years, using tools such as long-lasting insecticide-treated bed nets and artemisinin-based therapies. Malaria is also a significant cause of life-threatening imported infection in the UK. It is vital for front line clinical staff involved in the assessment of acutely ill patients to be aware of the need for early diagnostic testing, malaria epidemiology, markers of severe infection and developments in antimalarial treatments to optimise patient management. The difference between a good and poor outcome is early diagnosis and treatment. Many of the challenges faced in the quest for global eradication, such as availability of appropriate diagnostic tests, and drug and insecticide resistance could also have future implications for imported malaria.

Identifiants

pubmed: 30872301
pii: 19/2/153
doi: 10.7861/clinmedicine.19-2-153
pmc: PMC6454370
doi:

Substances chimiques

Antimalarials 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

153-156

Informations de copyright

© Royal College of Physicians 2019. All rights reserved.

Références

Parasitology. 2014 Dec;141(14):1873-9
pubmed: 25216364
Trends Parasitol. 2001 Dec;17(12):593-7
pubmed: 11756044
Lancet. 2010 Nov 13;376(9753):1647-57
pubmed: 21062666
BMJ. 2012 Mar 27;344:e2116
pubmed: 22454091
BMJ. 2015 Apr 16;350:h1703
pubmed: 25882309
Lancet. 2018 Apr 21;391(10130):1577-1588
pubmed: 29655496
Clin Infect Dis. 2015 Mar 15;60(6):930-6
pubmed: 25452593
Antimicrob Agents Chemother. 2017 Feb 23;61(3):
pubmed: 28137810
Lancet. 2015 Jul 4;386(9988):31-45
pubmed: 25913272
J Infect. 2016 Jun;72(6):635-649
pubmed: 26880088
Lancet. 2005 Aug 27-Sep 2;366(9487):717-25
pubmed: 16125588
PLoS One. 2010 Jan 25;5(1):e8091
pubmed: 20111602
BMC Med. 2015 Jul 25;13:167
pubmed: 26208740
Lancet. 2018 Apr 21;391(10130):1608-1621
pubmed: 29631781
N Engl J Med. 2014 Jul 31;371(5):411-23
pubmed: 25075834

Auteurs

Tommy Rampling (T)

Hospital for Tropical Diseases, London, UK t.rampling@ucl.ac.uk.

Colin J Sutherland (CJ)

Department of Immunology and Infection, London School of Hygiene & Tropical Medicine, London, UK.

Christopher Jm Whitty (CJ)

Hospital for Tropical Diseases, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH